Revvity to Present at J.P. Morgan Healthcare Conference
- None.
- None.
President and Chief Executive Officer Prahlad Singh will provide an update on the Company and its strategic priorities.
To access the presentation, a live audio webcast will be available via this page. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2022 revenue of more than
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231219924888/en/
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Media Relations:
Chet Murray
(781) 663-5719
chet.murray@revvity.com
Source: Revvity
FAQ
What time will Revvity, Inc. (NYSE: RVTY) present at the J.P. Morgan Healthcare Conference?
Who will provide the update at the 42nd annual J.P. Morgan Healthcare Conference for Revvity, Inc. (NYSE: RVTY)?
How can I access the live audio webcast of Revvity, Inc. (NYSE: RVTY) presentation at the J.P. Morgan Healthcare Conference?